1. INTRODUCTION

One of the most consistent and potentially dangerous side effects of anabolic-androgenic steroid use is secondary polycythemia, commonly called “high RBC” or “thick blood.” This occurs when red blood cell production rises sharply, pushing hematocrit, hemoglobin, and overall blood viscosity upward.

Many AAS compounds stimulate erythropoietin release in the kidneys, which signals the bone marrow to manufacture more red blood cells. While this can improve oxygen delivery to working muscles in the short term, excessive elevation makes the blood sluggish and difficult to pump through the vascular network.

2. GUILTY COMPOUNDS

Compounds such as Boldenone (Equipoise), high-dose Testosterone (especially above 750–1000 mg/week), Trenbolone, Anadrol, and DHB tend to produce the most pronounced increases. That being said, almost every single AAS contributes to some degree, particularly during extended cycles or with aggressive dosing.

3. OPTIMAL LEVELS

Hematocrit levels in the mid-50s are common on heavy protocols, and readings above 54% enter high-risk territory. Normal values for men fall between 40% and 50%, so crossing into the 52–54% range already places significant strain on the cardiovascular system.

4. THE DANGER OF HIGH RBC

Thick blood dramatically increases the risk of serious events:

• Blood clots (deep vein thrombosis or pulmonary embolism)
• Stroke
• Heart attack
• Chronic high blood pressure
• Reduced oxygen delivery to tissues (despite higher red cell count)
• Persistent headaches, dizziness, ruddy complexion, fatigue, and visual disturbances

When left unmanaged, polycythemia ranks among the quickest routes to emergency medical intervention for enhanced athletes.

5. HOW TO MITIGATE IT

The single most effective intervention is therapeutic phlebotomy or regular blood donation. Removing approximately 450–500 ml of whole blood lowers hematocrit by several points within days and provides relief that typically lasts six to twelve weeks, depending on how rapidly the cycle drives red blood cell production.

Donating at a certified blood bank is free and benefits others, while therapeutic phlebotomy performed in a clinical setting usually costs between $100 and $200 per session.

Experienced users often schedule donations or phlebotomy every eight to ten weeks while running compounds known to elevate hematocrit aggressively.

However, certain measures can be taken to eliminate the need for phlebotomies or donations, or at least to reduce how frequently they are needed:

• Low-dose aspirin taken daily at 81 mg to 100 mg serves as a reliable safeguard. It inhibits platelet aggregation and reduces the chance of clot formation without substantially raising bleeding risk for most individuals.
• Nattokinase, dosed at 100–200 mg per day with a potency of 2,000–4,000 FU, helps break down fibrin and promotes smoother circulation.
• Serrapeptase, taken at 40,000–120,000 SU on an empty stomach, provides strong anti-inflammatory and fibrinolytic action.
• Hydration remains one of the most underappreciated yet highly effective tools. Consuming five to six liters of water daily, or more during intense training or hot conditions, expands plasma volume and can reduce hematocrit by two to four points. Consistent high fluid intake stands out as one of the easiest, least expensive, and most impactful ways to maintain healthier viscosity.
• Regular cardiovascular exercise contributes significantly as well. Three to five moderate-intensity sessions per week, lasting twenty to forty-five minutes each, improve endothelial function, enhance overall blood flow, and help regulate red blood cell production over time. The goal here is not calorie burn but vascular resilience under the added stress of elevated red cells.
• Smart dosing and compound selection play a critical role in prevention. Reducing the amount of high-hematocrit offenders or substituting them with compounds that produce milder increases, such as Primobolan or Masteron, often brings levels back into a safer range without frequent intervention. Planned breaks or lower-dose cruise periods allow the body to normalize before the next push.
• Supportive supplements can add further protection. IP6 (inositol hexaphosphate) at 500–1000 mg daily, high-potency fish oil delivering three to four grams of EPA and DHA, and curcumin combined with piperine offer anti-inflammatory and circulation benefits that layer nicely with the primary strategies.

6. MONITORING GUIDELINES

Monitoring forms the backbone of effective management. A complete blood count should be performed every four to six weeks during active cycles, with more frequent checks during heavy blasts. Hematocrit, hemoglobin, and red blood cell count should be tracked closely. When levels reach 52%, intensify hydration, enzymes, and aspirin. At 54%, schedule donation or phlebotomy without delay.

7. CONCLUSION

AAS-induced hypertension is predictable, multifactorial, and almost always manageable when identified early. The combination of regular monitoring, rational compound selection, dietary discipline, cardiovascular exercise, and appropriately chosen antihypertensive medication allows most users to keep blood pressure within safe limits while still achieving their physique or performance goals.